ConductScience.org, home

Paper10692049

Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required.

Podolin PL and 4 others. Immunology, 2000. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required. Papers, record 10692049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10692049

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required.
PubMed
Journal
Immunology
PubMed
Year
2000
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2019-05-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Podolin PLP L
2Webb EFE F
3Reddy MM
4Truneh AA
5Griswold DED E

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4-Positive T-LymphocytesMajor topic
Dermatitis, ContactMajor topic
Adjuvants, Immunologic
Animals
Antibodies, Monoclonal
CD4 Antigens
Dose-Response Relationship, Immunologic
Humans
Immune Tolerance
Interferon-gamma
Interleukin-4
Mice
Mice, Transgenic
Oxazolone

Source PubMed

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,673,704Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation.J Immunol1995https://conductscience.org/library/papers/7673704PubMed
27,821,755A structural view of CD4 and CD8.FASEB J1995https://conductscience.org/library/papers/7821755PubMed
38,559,607Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.Pediatr Res1995https://conductscience.org/library/papers/8559607PubMed
48,575,197CD4 and signal transduction.Curr Top Microbiol Immunol1996https://conductscience.org/library/papers/8575197PubMed
58,575,199The regulation and function of the CD4 coreceptor during T lymphocyte development.Curr Top Microbiol Immunol1996https://conductscience.org/library/papers/8575199PubMed
68,596,036Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles.J Immunol1996https://conductscience.org/library/papers/8596036PubMed
78,618,064Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse.J Invest Dermatol1996https://conductscience.org/library/papers/8618064PubMed
88,642,241
T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
J Exp Med1996https://conductscience.org/library/papers/8642241PubMed
98,805,674Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.J Immunol1996https://conductscience.org/library/papers/8805674PubMed
109,058,767Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice.J Neuroimmunol1997https://conductscience.org/library/papers/9058767PubMed
119,191,886A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.Clin Immunol Immunopathol1997https://conductscience.org/library/papers/9191886PubMed
129,278,342Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile.J Immunol1997https://conductscience.org/library/papers/9278342PubMed
139,366,431Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.J Immunol1997https://conductscience.org/library/papers/9366431PubMed
149,665,392Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4.J Invest Dermatol1998https://conductscience.org/library/papers/9665392PubMed
159,798,587Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma.Lancet1998https://conductscience.org/library/papers/9798587PubMed
1610,384,148Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.J Immunol1999https://conductscience.org/library/papers/10384148PubMed
173,919,141Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.J Exp Med1985https://conductscience.org/library/papers/3919141PubMed
1810,657,642Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4.J Immunol2000https://conductscience.org/library/papers/10657642PubMed
1910,944,754Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibody.Methods Enzymol2000https://conductscience.org/library/papers/10944754PubMed
206,972,973Hapten-specific T cell response to 4-hydroxy-3-nitrophenyl acetyl. X. Characterization of distinct T cell subsets mediating cutaneous sensitivity responses.J Immunol1981https://conductscience.org/library/papers/6972973PubMed

See all 43 references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
31,502,016Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.Ann Surg Oncol2019https://conductscience.org/library/papers/31502016PubMed
30,021,009Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice.PLoS One2018https://conductscience.org/library/papers/30021009PubMed
20,065,651Preclinical development of monoclonal antibodies: considerations for the use of non-human primates.MAbs2009https://conductscience.org/library/papers/20065651PubMed
20,046,568Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies.MAbs2009https://conductscience.org/library/papers/20046568PubMed
11,160,000Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.Infect Immun2001https://conductscience.org/library/papers/11160000PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10692049

GET https://conductscience.org/api/papers/v1/10692049/references?page=2